BIOMAT Database Logo BIOMAT Database Logo

Polymorphism of the proto-oncogene ETS-1 in hematological malignancies. 1990

J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Unité 124 INSERM, Institut de Recherches sur le Cancer, Lille, France.

We studied a novel restriction fragment length polymorphism (RFLP) of the proto-oncogenes ETS-1 that we detected in a patient with an acute monocytic leukemia by the presence of two, 3.7 and 10 kb, Xbal fragments on Southern blots of DNA from blast cells and remission blood samples. RFLP analysis of a series of 114 normal donors revealed that only four (3.6%) shared the 10 kb fragment. By contrast, this unusual allele was found in 20 (all lymphocytic or monocytic) of 108 (18.5%) hematological malignancies (p less than 0.001). DNA sequence analysis indicated the disappearance in the rare allele of a Xbal site due to a single point mutation at the 3' end of ETS-1 locus. Molecular consequences of this mutation point to a possible pathogenic involvement of ETS-1 in these disorders and to the question of genetic susceptibility to hematological malignancies.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090063 Proto-Oncogene Mas A protein that is encoded by the MAS1 gene. It is a receptor for ANGIOTENSIN 1-7 and acts as an antagonist of ANGIOTENSIN-2 TYPE 1 RECEPTOR. C-Mas Protein,II-Proto-Oncogene Proteins, Cellular,Mas Protein,Mas1 Protein,Proto-Oncogene Protein Mas,Proto-Oncogene Proteins C-Mas-1,C Mas Protein,C-Mas-1, Proto-Oncogene Proteins,Cellular II-Proto-Oncogene Proteins,II Proto Oncogene Proteins, Cellular,Mas, Proto-Oncogene,Protein Mas, Proto-Oncogene,Protein, C-Mas,Protein, Mas,Protein, Mas1,Proteins, Cellular II-Proto-Oncogene,Proto Oncogene Mas,Proto Oncogene Proteins C Mas 1
D000754 Anemia, Refractory, with Excess of Blasts Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. Leukemia, Smoldering,RAEB,RAEM,Refractory Anemia with Excess of Blasts,Leukemia, Smouldering,Leukemias, Smoldering,Smoldering Leukemia,Smoldering Leukemias,Smouldering Leukemia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Proto-oncogene Ets-1 and the kidney.
September 2001, Nephron,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Expression of the ets-1 proto-oncogene in melanocytic lesions.
August 2003, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Expression of the ets-1 proto-oncogene in human thyroid tumor.
January 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
February 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
May 2001, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
January 2022, Bioengineered,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines.
January 1989, Nouvelle revue francaise d'hematologie,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.
February 2005, Histopathology,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Characterization of Xenopus laevis cDNA clones of the c-ets-1 proto-oncogene.
September 1990, Nucleic acids research,
J P Kerckaert, and M Duterque-Coquillaud, and M Collyn-d'Hooghe, and P Morel, and M A Majérus, and J L Laï, and P Fenaux, and F Bauters, and B Debuire, and M H Loucheux-Lefebvre
Chromosomal localization of the human proto-oncogene c-ets.
January 1984, Nature,
Copied contents to your clipboard!